Title: Vitamins China Monthly Report – June 2026 Commentary
Company dynamics
- In late May 2026, Dsm-firmenich announced that its shares had officially commenced trading on the SIX Swiss Exchange.
- In late May 2026, Xidian Pharma announced that its subsidiary had received a Drug Registration Certificate for Vitamin B6 Injection.
- On 27 May, 2026, CSPC released its Q1 2026 financial report.
- On 9 June, 2026, Garden Bio signed an exclusive European distribution agreement with Denkavit for vitamin products including vitamin A, D3, and B6.
Project progress
- On 29 May, 2026, the EI report for Champtone's 5,110.2 t/a biological core raw materials upgrading project was announced for approval.
- On 2 June, 2026, the EI report for Xiushantang Pharma's 6,800 t/a health nutrition food project was accepted.
- On 6 June, 2026, Tianchen Qixiang initiated the tender for its 12,000 t/a 3-methylpyridine project.
- On 9 June, 2026, the EI report for Shandong Shangru's 70 t/a vitamin K3 pilot test project was proposed for approval.
The USD/RMB exchange rate in this Report is USD1.00=CNY6.8167 on 1 June, 2026, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Buy Now
Add to cart
